Published in Ther Deliv on April 01, 2011
Safety Study of CALAA-01 to Treat Solid Tumor Cancers | NCT00689065
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00009841
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia | NCT01064440
Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules (2011) 1.49
A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles. Small (2011) 1.25
Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. Mol Pharm (2012) 1.22
Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer. Adv Healthc Mater (2012) 1.18
Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation. Biomaterials (2012) 1.11
Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One (2012) 1.06
The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. J Am Chem Soc (2013) 1.06
2011 Rita Schaffer lecture: nanoparticles for intracellular nucleic acid delivery. Ann Biomed Eng (2012) 0.97
Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s. J Biomed Mater Res A (2013) 0.92
Branched polyethylenimine-grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo. Int J Nanomedicine (2013) 0.91
Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo. Mol Cancer Ther (2013) 0.90
Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA. Acta Biomater (2014) 0.88
Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response. Cell Res (2015) 0.83
Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine. Ann Biomed Eng (2013) 0.82
Nanoparticle-mediated transcriptional modification enhances neuronal differentiation of human neural stem cells following transplantation in rat brain. Biomaterials (2016) 0.79
Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry. Acta Biomater (2016) 0.76
Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications. J Control Release (2015) 0.75
Polymeric nanoparticle-based delivery of TRAIL DNA for cancer-specific killing. Bioeng Transl Med (2016) 0.75
Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles. J Control Release (2015) 0.75
Nanoparticle-mediated conversion of primary human astrocytes into neurons and oligodendrocytes. Biomater Sci (2016) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell (2000) 20.32
A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 19.34
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev (2004) 13.49
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc (2006) 11.99
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials (2005) 11.01
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev (2002) 10.71
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
Endocytosis and molecular sorting. Annu Rev Cell Dev Biol (1996) 8.83
Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science (1998) 8.51
Oxidized redox state of glutathione in the endoplasmic reticulum. Science (1992) 6.91
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett (2005) 6.02
Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A (1962) 5.94
Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem (2006) 5.34
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol (2007) 5.05
Effect of surface properties on nanoparticle-cell interactions. Small (2010) 4.98
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater (2008) 4.81
Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett (2005) 4.70
Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem (2003) 4.40
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 4.04
Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm (2008) 3.92
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol (2008) 3.78
Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett (2005) 3.65
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem (2004) 3.52
The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm (2009) 3.49
Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med (1999) 3.36
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev (2003) 3.25
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem (1994) 3.24
Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods (2006) 3.24
Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol Biol Cell (2002) 3.20
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther (1999) 2.90
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater (2009) 2.87
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release (2001) 2.84
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther (2005) 2.83
Polymers for gene delivery across length scales. Nat Mater (2006) 2.79
Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett (2005) 2.76
Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release (2007) 2.74
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther (2008) 2.69
Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A (1990) 2.64
A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63
Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A (1999) 2.58
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target (2007) 2.50
Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng (2000) 2.49
Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2003) 2.37
In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem (1997) 2.28
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem (1987) 2.25
Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A (2005) 2.23
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther (1999) 2.17
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol (2004) 2.13
The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett (2006) 2.09
Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem (2001) 2.06
Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotechnol (2006) 2.03
siRNA and isRNA: two edges of one sword. Mol Ther (2006) 2.02
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02
Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett (2009) 1.95
Selective release of multiple DNA oligonucleotides from gold nanorods. ACS Nano (2009) 1.95
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A (2010) 1.92
Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. Proc Natl Acad Sci U S A (1975) 1.89
Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther (2005) 1.87
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res (2010) 1.87
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A (1992) 1.87
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86
Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing. Nat Methods (2005) 1.83
Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 1.81
Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed (2006) 1.79
Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem (2006) 1.79
A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A (2004) 1.79
Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett (2008) 1.78
Antiangiogenic properties of gold nanoparticles. Clin Cancer Res (2005) 1.78
Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med (2001) 1.78
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res (2007) 1.77
Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem (1999) 1.76
The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release (2009) 1.74
DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation. J Am Chem Soc (2006) 1.67
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci (2005) 1.61
Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Protoc (2009) 1.61
Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconjug Chem (2006) 1.58
Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol (2006) 1.57
Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem (2002) 1.55
Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release (2003) 1.54
Medicinal applications of fullerenes. Int J Nanomedicine (2007) 1.53
Gene therapy put on hold as third child develops cancer. Nature (2005) 1.48
Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci (2010) 1.45
Surface-mediated gene transfer from nanocomposites of controlled texture. Nat Mater (2004) 1.45
New frontiers in nanotechnology for cancer treatment. Urol Oncol (2008) 1.42
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biol Ther (2004) 1.40
Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug Chem (2004) 1.40
Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol (1990) 1.38
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86
Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma. Biomaterials (2011) 1.85
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A (2009) 1.83
Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery. Biomacromolecules (2011) 1.49
The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures. Biomaterials (2010) 1.37
Tissue-specific gene delivery via nanoparticle coating. Biomaterials (2009) 1.34
Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res (2009) 1.27
A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles. Small (2011) 1.25
Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties. Mol Pharm (2012) 1.22
Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer. Adv Healthc Mater (2012) 1.18
Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation. Biomaterials (2012) 1.11
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells. Cancer Biol Ther (2008) 1.10
Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One (2012) 1.06
Gene delivery nanoparticles specific for human microvasculature and macrovasculature. Nanomedicine (2012) 1.06
The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. J Am Chem Soc (2013) 1.06
Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells. Int J Nanomedicine (2011) 1.01
Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells. ACS Nano (2014) 0.97
Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano (2014) 0.97
Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano (2015) 0.96
Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cells. Bioconjug Chem (2013) 0.94
Electrostatic surface modifications to improve gene delivery. Expert Opin Drug Deliv (2010) 0.94
Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis. Expert Opin Drug Deliv (2011) 0.92
Therapeutic nanomedicine for brain cancer. Ther Deliv (2013) 0.92
Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s. J Biomed Mater Res A (2013) 0.92
A bioreducible linear poly(β-amino ester) for siRNA delivery. Chem Commun (Camb) (2013) 0.91
Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo. Mol Cancer Ther (2013) 0.90
Nanoengineering approaches to the design of artificial antigen-presenting cells. Nanomedicine (Lond) (2013) 0.88
Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide. Biomaterials (2013) 0.83
Obesity and left ventricular assist device driveline exit site infection. ASAIO J (2010) 0.83
Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine. Ann Biomed Eng (2013) 0.82
Independent versus cooperative binding in polyethylenimine-DNA and Poly(L-lysine)-DNA polyplexes. J Phys Chem B (2013) 0.80
Poly(β-amino ester)-DNA complexes: time-resolved fluorescence and cellular transfection studies. J Control Release (2011) 0.79
Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation. Small (2015) 0.79
Bioengineered nanoparticles for siRNA delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.78
Degradable polymers for gene delivery. Conf Proc IEEE Eng Med Biol Soc (2009) 0.78
Therapeutic angiogenesis using genetically engineered human endothelial cells. J Control Release (2012) 0.77
Evaluation of polymeric gene delivery nanoparticles by nanoparticle tracking analysis and high-throughput flow cytometry. J Vis Exp (2013) 0.77
(3-aminopropyl)-4-methylpiperazine end-capped poly(1,4-butanediol diacrylate-co-4-amino-1-butanol)-based multilayer films for gene delivery. ACS Appl Mater Interfaces (2013) 0.76
Highlights from the latest articles in nanomedicine. Nanomedicine (Lond) (2014) 0.75
siRNA nanomedicine: the promise of bioreducible materials. Expert Rev Med Devices (2013) 0.75
Noninvasive predictor of HeartMate XVE pump failure by neural network and waveform analysis. ASAIO J (2010) 0.75